{"id":"bisbentiamine","rwe":[{"pmid":"7182450","year":"1982","title":"[Studies on the evaluation of bioavailability of oral solid formulation. V. Effects of diets on the bioavailability of bisbentiamine experimental tablets and their relation to physiological and formulation factors].","finding":"","journal":"Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan","studyType":"Clinical Study"}],"tags":[{"label":"bisbentiamine","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":["bisbentiamine"],"offLabel":[],"synonyms":["bisbentiamine"],"timeline":[],"ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"bisbentiamine","explanation":"Imagine your body's cells have locks on them, and bisbentiamine is a key that fits into one of those locks. When it binds, it can either unlock or block the lock, depending on how it interacts with the target. However, since its target is unknown, we can't say exactly how it works.","oneSentence":"Bisbentiamine is a small molecule that works by interacting with a specific target in the body, but its exact mechanism is unknown.","technicalDetail":"Bisbentiamine's mechanism of action is currently unknown, and further research is needed to elucidate its pharmacological effects."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/378","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=BISBENTIAMINE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T09:03:56.964711","biosimilars":[],"competitors":[],"genericName":"bisbentiamine","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"MEI78CAM16","CHEBI":"CHEBI:31288","INN_ID":"1469","UMLSCUI":"C0618327","ChEMBL_ID":"CHEMBL2105814","KEGG_DRUG":"D01284","PUBCHEM_CID":"3034022","SNOMEDCT_US":"703402008","MESH_SUPPLEMENTAL_RECORD_UI":"C037583"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":1,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[{"date":"1982 Dec","pmid":"7182450","title":"[Studies on the evaluation of bioavailability of oral solid formulation. V. Effects of diets on the bioavailability of bisbentiamine experimental tablets and their relation to physiological and formulation factors].","journal":"Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","brandName":"BISBENTIAMINE","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Bisbentiamine is a small molecule drug in the bisbentiamine class, but its target and mechanism of action are unknown. Its commercial status and approved indications are also unclear. As a result, there is limited information available on its safety profile, pharmacokinetics, or generic availability. Further research is needed to fully understand this compound. Its development history is also unclear.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}